StonvexLoading…
StonvexStonvexStonvexCore line items from TNDM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.01B | $940.20M | $747.72M | $801.22M |
Operating Income | $-187.26M | $-99.13M | $-233.23M | $-92.85M |
Net Income | $-204.71M | $-96.03M | $-222.61M | $-94.59M |
EPS (Diluted) | $-3.04 | $-1.47 | $-3.43 | $-1.47 |
Total Assets | $881.11M | $967.66M | $952.66M | $1.05B |
Total Liabilities | $725.94M | $704.56M | $639.03M | $612.84M |
Cash & Equivalents | $90.63M | $69.23M | $58.87M | $172.52M |
Free Cash Flow OCF − CapEx | $-29.67M | $4.99M | $-58.61M | $16.37M |
Shares Outstanding | 68.29M | 66.26M | 65.55M | 64.51M |